Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Clinical Study of BBI503 in Adult Patients With Advanced Solid Tumors

NCT01781455 is registered in ClinicalTrials.gov with Sumitomo Pharma America, Inc. as lead sponsor.

NCT NCT01781455
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01781455 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Clinical Study of BBI503 in Adult Patients With Advanced Solid Tumors
Lead sponsor
Sumitomo Pharma America, Inc.
Phase
Phase 1
Overall status
Completed
Start date
February 29, 2012
Completion date
June 30, 2020
Enrollment
311 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, advanced solid tumors